Other immunisation & vaccination

All Items

• Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia

  Julia ML Brotherton, Shelley L Deeks, Sue Campbell-Lloyd, Avner Misrachi, Irene Passaris, Karen Peterson, Helen Pitcher, Megan Scully, Maureen Watson, Rosalind Webby

  457-461

• What do we know about 7vpcv coverage in Aboriginal and Torres Strait Islander children? A 2007 update

  Brynley P Hull, Shelley Deeks, Robert Menzies, Peter B McIntyre

  257-260

• School-based vaccinations delivered by general practice in rural north Queensland: an evaluation of a new human papilloma virus vaccination program

  Carole Reeve, Stephanie De La Rue, Dennis Pashen, Margaret Culpan, Tracy Cheffins

  94-98

• Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2007

  Glenda L Lawrence, Padmasiri E Aratchige, Richard Hill

  379-382

• How reliable are Australian Childhood Immunisation Register coverage estimates for Indigenous children? An assessment of data quality and coverage

  Claudia Rank, Robert I Menzies

  283-287

• Compliance with three simultaneous vaccinations due at the one visit at 12 months of age in Australia

  Brynley P Hull, Peter B McIntyre

  198-202

• Pertussis epidemiology in Australia over the decade 1995–2005 – trends by region and age group

  Helen E Quinn, Peter B McIntyre

  205-215

• Supplementary report: surveillance of adverse events following immunisation among children aged <7 years in Australia, 1 January to 30 June 2006

  Glenda Lawrence, Ian Boyd

  438-442

• Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2005

  Glenda Lawrence, Ian Boyd

  413-416

• The Acceptance of three simultaneous vaccine injections recommended at 12 months of age

  Jeffrey N Hanna, Ruth C Bullen, Debora E Andrews

  493-496

• Top End rural and remote Indigenous women: an Australian population group vulnerable to rubella

  Jennifer M Hunt, Judith Lumley

  499-503

• Influenza A associated morbidity and mortality in a Paediatric Intensive Care Unit

  Bronwyn G Milne, Stephen Williams, Meryta L A May, Alison M Kesson, Jonathan Gillis, Margaret A Burgess

  504-509

• The Cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine use

  Stephen Lambert, Kerry-Ann O'Grady, Susan Gabriel, Robert Carter, Terry Nolan

  509-516

• Surveillance of adverse events following immunisation: Australia 2002 to 2003

  Glenda Lawrence, Ian Boyd, Peter McIntyre, David Isaacs

  324-338

• Planning for human papillomavirus vaccines in Australia: Report of a research group meeting

  Julia Brotherton, Peter B McIntyre

  249-254

• National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases

  National Centre for Immunisation Research and Surveillance

  92-95

• Interruption of rubella virus transmission in Australia may require vaccination of adult males: evidence from a Victorian sero-survey

  Heath Kelly, Theo Karapanagiotidis

  69-73

• Prevention of opportunistic infections in immunosuppressed patients in the tropical Top End of the Northern Territory of Australia

  Bart J Currie, Jashua S Davis, Dale A Fisher, Sarah E Huffam, Nicholas M Anstey, Richard N Price, Vicki L Krause, Nathan Zweck, Paul D Lawton, Paul L Snelling, Sid Selva-Nayagam

  526-532

• Rubella in Australia: can we explain two recent cases of congenital rubella syndrome?

  Heather Gidding, Margaret Young, Robyn Pugh, Margaret Burgess

  537-540

• The National Immunisation Committee

  The National Immunisation Committee

  548-550

• Estimating immunisation coverage: is the 'third dose assumption' still valid?

  Brynley P Hull, Glenda L Lawrence, C Raina MacIntyre, Peter B McIntyre

  357-361

• Editorial: Introduction of the National Meningococcal C Vaccination Program

  Natalie J Cohen

  161-162

• The Australian Technical Advisory Group on Immunisation

  George Rubin

  277-279

• Uptake of influenza vaccine among Aboriginal and Torres Strait Island adults in north Queensland, 2002

  Jeffrey N Hanna, Bradley G McCulloch

  102-104

• Varicella vaccine in post-exposure prophylaxis

  Mark J Ferson

  13-15

• Immunisation coverage estimates

  Christine Selvey

  260

• A Re-evaluation of immunisation coverage estimates from the Australian Childhood Immunisation Register

  Brynley P Hull, Peter B McIntyre

  161-164

• Current issues in immunisation: Diphtheria in Australia, recent trends and future prevention strategies

  Heather F Gidding, Margaret A Burgess, Gwendolyn L Gilbert

  165-167

• Factors influencing vaccination uptake (Workshop Report: Current Australian research on the behavioural, social and demographic factors influencing immunisation, Royal Alexandra Hospital for Children, Sydney, March 1998)

  Jill M Forrest, Margaret A Burgess, Peter B McIntyre

  5-53

• Adverse Events Following Immunisation associated with the 1998 Australian Measles Control Campaign

  Rennie M D'Souza, Sue Campbell-Lloyd, David Isaacs, Michael Gold, Margaret Burgess, Fiona Turnbull, Eddie O'Brien

  27-33

• An Outbreak of measles in a rural Queensland town in 1997: an opportunity to assess vaccine effectiveness

  Heather F Gidding, Susan Hills, Linda Selvey, Leslee A Roberts, Susan Johnston

  240-245

• The Epidemiology of rubella and congenital rubella in Australia, 1992 to 1997

  Eleanor M Sullivan, Margaret A Burgess, Jill M Forrest

  209-214

• Current issues in immunisation: Measles-Mumps-Rubella immunisation, autism and inflammatory bowel disease: update

  Janaki Amin, Melanie Wong

  222

• Immunisation coverage in Australian children: a systematic review 1990-1998

  Susan Lister, Peter B McIntyre, Margaret A Burgess, Eddie D O'Brien

  145-170

• Rubella infection in pregnancy

  Christopher Coulter, Robyn Wood, Jenny Robson

  93-96

• Measles Control Campaign update (Measles Control Campaign activity data, cumulative to 25 November 1998)

  Sue Campbell-Lloyd

  270

• Measles Control Campaign update (Measles Control Campaign activity data, cumulative to 25 September 1998)

  Sue Campbell-Lloyd

  253

• Current issues in immunisation (Immunisation of preterm infants)

  SJ Botham, D Issacs, MA Burgess

  218-220

• Measles Control Campaign update (Measles Control Campaign activity data, cumulative to 25 September 1998)

  Sue Campbell-Lloyd

  220

• National Health and Medical Research Council recommendations on diphtheria vaccination

  No authors listed

  188

• Measles Control Campaign update (Measles Control Campaign activity data, to 26 August 1998)

  Sue Campbell-Lloyd

  193

• Change to the Australian Standard Vaccination Schedule

  No authors listed

  156

• Immunise Australia Program: Measles Control Campaign

  No authors listed

  156

• Current issues in immunisation (Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella)

  Timothy C Heath, Margaret A Burgess, Jill M Forrest

  157-158

• Current issues in immunisation (Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines)

  Timothy C Heath, Margaret A Burgess, Eddie D O'Brien

  159

• Pertussis vaccines: past, present and future in Australia Proceedings of a workshop held at the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Royal Alexandra Hospital for Children and University of Sydney, Westmead, New South Wales, 9 August 1997

  Peter McIntyre, Jill Forrest, Tim Heath, Margaret Burgess, Bronwen Harvey

  125-132

• Current issues in immunisation (The Measles Control Campaign and immunisation adverse events)

  Margaret A Burgess, Timothy C Heath, Peter B McIntyre

  136-138

• Current issues in immunisation (Measles vaccine, inflammatory bowel disease and pervasive developmental disorder: is there cause for concern?)

  Janaki Amin, Peter B McIntyre, Timothy C Heath

  58-59

• Methodology for measuring Australia's childhood immunisation coverage

  Edward D O'Brien, Greg A Sam, Cathy Mead

  36-37

• Current issues in immunisation (immunisation and asthma)

  Peter B McIntyre, Edward D O'Brien, Timothy C Heath

  38

• National Health and Medical Research Council recommendations on diphtheria vaccination

  No authors listed

  165

• Correspondence: Accelerated primary immunisation schedule; Reply from the author; Editorial comment

  Michael Sorokin, David Sloan

  284-285

• Haemophilus Influenzae type b vaccination coverage in the Australia Capital Territory for children aged nine months and two years

  Eddie O'Brien, Ann Kempe

  256-258

• Immunisation coverage of two year old children in child-care centres in Illawarra and Shoalhaven regions of New South Wales

  Glenis Lloyd

  217-218

• Editorial: Measuring immunisation coverage

  Robert Hall

  219

• Notice to readers: Adult tetanus vaccination level survey 1996, South Australia

  No authors listed

  220

• Vaccination against Japanese encephalitis in the Torres Strait

  Jeffrey Hanna, Dianne Barnett, Dan Ewald

  188-190

• Pertussis and the acellular vaccines

  Margaret Burgess, Jill Forrest

  192-196

• Influenza vaccine formula for the northern winter 1996-1997

  No authors listed

  146-147

• Correspondence: Composition of influenza vaccine for the southern hemisphere winter, 1996

  John Cable

  148